Literature DB >> 19945490

Phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from children with acute respiratory infections in Yamagata, Japan.

Katsumi Mizuta1, Asumi Hirata, Asuka Suto, Yoko Aoki, Tadayuki Ahiko, Tsutomu Itagaki, Hiroyuki Tsukagoshi, Yukio Morita, Masatsugu Obuchi, Miho Akiyama, Nobuhiko Okabe, Masahiro Noda, Masato Tashiro, Hirokazu Kimura.   

Abstract

We performed phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from 76 children with acute respiratory infection in Yamagata prefecture, Japan during the period 2003-2007. Phylogenetic trees based on the nucleotide and amino acid sequences of the VP4/VP2 coding region showed that the present strains could be classified into 11 and 8 clusters, respectively. The homology among the present strains ranged from 66.6% to 100% at the nucleotide level and 84.7% to 100% at the amino acid level. The interspecies distance (mean+/-standard deviation) was calculated to be 0.235+/-0.048 at the nucleotide level and 0.076+/-0.033 at the amino acid level. In addition, the phylogenetic trees created based on the nucleotide and amino acid sequences showed that HRV-A strains belonging to some clusters were associated with both upper respiratory infection and wheezy bronchiolitis, while other strains were associated with upper respiratory infection alone. These results suggest that the present HRV-A isolates had a wide nucleotide divergence and were associated with acute respiratory infection, including upper respiratory infection and wheezy bronchiolitis, in Yamagata prefecture, Japan during the investigation period. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945490     DOI: 10.1016/j.virusres.2009.11.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Sequencing human rhinoviruses: direct sequencing versus plasmid cloning.

Authors:  Jodell E Linder; Tatyana E Plachco; Romina Libster; E Kathryn Miller
Journal:  J Virol Methods       Date:  2014-10-05       Impact factor: 2.014

2.  Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.

Authors:  Mutsuo Yamaya; Hidekazu Nishimura; Yukimasa Hatachi; Hiroyasu Yasuda; Xue Deng; Takahiko Sasaki; Katsumi Mizuta; Hiroshi Kubo; Ryoichi Nagatomi
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

3.  Clinical characteristics and genetic variability of human rhinovirus in Mexico.

Authors:  Adriana Landa-Cardeña; Jaime Morales-Romero; Rebeca García-Roman; Ana Georgina Cobián-Güemes; Ernesto Méndez; Cristina Ortiz-Leon; Felipe Pitalúa-Cortés; Silvia Ivonne Mora; Hilda Montero
Journal:  Viruses       Date:  2012-01-25       Impact factor: 5.048

4.  A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness.

Authors:  Asako Fujitsuka; Hiroyuki Tsukagoshi; Mika Arakawa; Kazuko Goto-Sugai; Akihide Ryo; Yoshimichi Okayama; Katsumi Mizuta; Atsuyoshi Nishina; Masakazu Yoshizumi; Yoichi Kaburagi; Masahiro Noda; Masato Tashiro; Nobuhiko Okabe; Masaaki Mori; Shumpei Yokota; Hirokazu Kimura
Journal:  BMC Infect Dis       Date:  2011-06-10       Impact factor: 3.090

5.  Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan.

Authors:  Katsumi Mizuta; Mika Saitoh; Miho Kobayashi; Hiroyuki Tsukagoshi; Yoko Aoki; Tatsuya Ikeda; Chieko Abiko; Noriko Katsushima; Tsutomu Itagaki; Masahiro Noda; Kunihisa Kozawa; Tadayuki Ahiko; Hirokazu Kimura
Journal:  Virol J       Date:  2011-12-13       Impact factor: 4.099

Review 6.  Molecular epidemiology of respiratory viruses in virus-induced asthma.

Authors:  Hiroyuki Tsukagoshi; Taisei Ishioka; Masahiro Noda; Kunihisa Kozawa; Hirokazu Kimura
Journal:  Front Microbiol       Date:  2013-09-12       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.